A Case Report of Reduction in Alcohol Craving and Protection Against Alcohol Withdrawal by Gabapentin
J Clin Psychiatry 1999;60(9):617 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: Gabapentin is a novel anticonvulsant that has been used in the treatment of epilepsy and, more recently, psychiatric disorders, including bipolar affective disorder, behavioral dyscontrol, and anxiety disorders. We have had good results in using it to augment selective serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder (OCD), with few, and generally benign, side effects. We describe here a serendipitous finding: a patient with OCD and comorbid, long-standing severe alcohol dependency lost his craving for alcohol and stopped drinking precipitously without signs of withdrawal approximately 3 weeks after beginning treatment with gabapentin.